Celecoxib--a rational alternative to NSAIDs.
Moodley
I
I
Department of Pharmacy, University of the Witwatersrand.
Hirsch
G
G
D000329:Advertising; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use*; D000068579:Celecoxib; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry; D017850:Economics, Pharmaceutical; D019317:Evidence-Based Medicine; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007258:Informed Consent; D007592:Joint Diseases / Q000188:drug therapy; D008389:Marketing of Health Services; D010353:Patient Education as Topic / Q000379:methods*; D011720:Pyrazoles; D013449:Sulfonamides / Q000191:economics / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib